Home LiteratureArticle Details
PMID: 2885982 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Involvement of cell envelope components in the pathogenesis of Vibrio cholerae: targets for cholera vaccine development.

Vaccine ·Vol. 5 ·No. 2 ·1987-06-00 ·Pages 83-7

Manning PA

Abstract

Parenteral cholera vaccines have for some years been removed from the WHO recommendations. With a greater understanding of the immunology of gut infections has come the realization that oral vaccines are the most promising approach. There are several possible approaches: killed vaccines, attenuated Vibrio cholerae and true recombinants in which V. cholerae protective antigens are introduced into suitable carrier strains. This latter approach has perhaps greater potential as a carrier strain can be chosen/developed which most effectively stimulates the local immune response in the gut. This necessitates the identification of the important protective antigens. These antigens are thought to be components of the cell envelope which are involved in adhesion and colonization.

MeSH Terms
Bacterial Outer Membrane Proteins/immunology Bacterial Vaccines/immunology Fimbriae, Bacterial/immunology Flagellin/immunology Hemagglutinins/immunology Lipopolysaccharides/immunology Polysaccharides, Bacterial/immunology Surface Properties Vibrio cholerae/immunology,pathogenicity
Chemicals
Bacterial Outer Membrane Proteins Bacterial Vaccines Hemagglutinins Lipopolysaccharides Polysaccharides, Bacterial Flagellin
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Manning P A
Article Info
Journal
Vaccine
Abbr.
Vaccine
ISSN
0264-410X
Published
1987-06-00
Pages
83-7
Language
English
Region
Netherlands
NLM ID
8406899
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com